Imprimis Fails To Nix Jury Award In Allergan False Ad Suit
Imprimis Pharmaceuticals has lost its bid in California federal court to overturn a $48,500 jury award in a case brought by Allergan USA Inc. accusing its rival of using false advertisements...To view the full article, register now.
Already a subscriber? Click here to view full article